Associations between colorectal cancer molecular markers and pathways with clinicopathologic features in older women

Gastroenterology

Volumn 145, Issue 2, 2013, Pages

  Samadder, N Jewel ^a   Vierkant, Robert A ^b   Tillmans, Lori S ^b   Wang, Alice H ^b   Weisenberger, Daniel J ^c   Laird, Peter W ^c   Lynch, Charles F ^d   Anderson, Kristin E ^e   French, Amy J ^b   Haile, Robert W ^f   Potter, John D ^g   Slager, Susan L ^b   Smyrk, Thomas C ^b   Thibodeau, Stephen N ^b   Cerhan, James R ^b   Limburg, Paul J ^b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d UNIVERSITY OF IOWA   (United States)

^e UNIVERSITY OF MINNESOTA   (United States)

^f UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^g Fred Hutchinson Cancer Research Center   (United States)

Author keywords

Molecular Epidemiology Colon Cancer Prognostic Factor Integrated Pathways

Indexed keywords

ANTINEOPLASTIC AGENT; B RAF KINASE; K RAS PROTEIN;

ADULT; AGE; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER SURVIVAL; CLINICAL FEATURE; COLORECTAL CANCER; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; WOMEN'S HEALTH;

EID: 84880632820     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2013.05.001     Document Type: Article

References (58)

1. A. Jemal, F. Bray, and M.M. Center Global cancer statistics CA Cancer J Clin 61 2011 69 90
2. M. Toyota, and J.P. Issa CpG island methylator phenotypes in aging and cancer Semin Cancer Biol 9 1999 349 357
3. D.J. Weisenberger, K.D. Siegmund, and M. Campan CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer Nat Genet 38 2006 787 793
4. W.S. Samowitz, H. Albertsen, and C. Sweeney Association of smoking, CpG island methylator phenotype, and V600E BRAF mutations in colon cancer J Natl Cancer Inst 98 2006 1731 1738
5. S. Lee, N.Y. Cho, and E.J. Yoo CpG island methylator phenotype in colorectal cancers: comparison of the new and classic CpG island methylator phenotype marker panels Arch Pathol Lab Med 132 2008 1657 1665
6. T. Nagasaka, M. Koi, and M. Kloor Mutations in both KRAS and BRAF may contribute to the methylator phenotype in colon cancer Gastroenterology 134 2008 1950 1960 1960 e1
7. S. Kakar, G. Deng, and V. Sahai Clinicopathologic characteristics, CpG island methylator phenotype, and BRAF mutations in microsatellite-stable colorectal cancers without chromosomal instability Arch Pathol Lab Med 132 2008 958 964
8. S. Ogino, K. Nosho, and G.J. Kirkner CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer Gut 58 2009 90 96
9. P.W. Ang, M. Loh, and N. Liem Comprehensive profiling of DNA methylation in colorectal cancer reveals subgroups with distinct clinicopathological and molecular features BMC Cancer 10 2010 227
10. C.R. Boland, and A. Goel Microsatellite instability in colorectal cancer Gastroenterology 138 2010 2073 2087 e3
11. B. Leggett, and V. Whitehall Role of the serrated pathway in colorectal cancer pathogenesis Gastroenterology 138 2010 2088 2100
12. R. Gafa, I. Maestri, and M. Matteuzzi Sporadic colorectal adenocarcinomas with high-frequency microsatellite instability Cancer 89 2000 2025 2037
13. A. Chao, F. Gilliland, and C. Willman Patient and tumor characteristics of colon cancers with microsatellite instability: a population-based study Cancer Epidemiol Biomarkers Prev 9 2000 539 544
14. S. Lee, N.Y. Cho, and M. Choi Clinicopathological features of CpG island methylator phenotype-positive colorectal cancer and its adverse prognosis in relation to KRAS/BRAF mutation Pathol Int 58 2008 104 113
15. G. Deng, S. Kakar, and H. Tanaka Proximal and distal colorectal cancers show distinct gene-specific methylation profiles and clinical and molecular characteristics Eur J Cancer 44 2008 1290 1301
16. T. Kambara, L.A. Simms, and V.L. Whitehall BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum Gut 53 2004 1137 1144
17. L. Shen, M. Toyota, and Y. Kondo Integrated genetic and epigenetic analysis identifies three different subclasses of colon cancer Proc Natl Acad Sci U S A 104 2007 18654 18659
18. J.R. Jass Classification of colorectal cancer based on correlation of clinical, morphological and molecular features Histopathology 50 2007 113 130
19. C. Sweeney, K.M. Boucher, and W.S. Samowitz Oncogenetic tree model of somatic mutations and DNA methylation in colon tumors Genes Chromosomes Cancer 48 2009 1 9
20. J.P. Issa Colon cancer: it's CIN or CIMP Clin Cancer Res 14 2008 5939 5940
21. I. Zlobec, and A. Lugli Prognostic and predictive factors in colorectal cancer J Clin Pathol 61 2008 561 569
22. G. Puppa, A. Sonzogni, and R. Colombari TNM staging system of colorectal carcinoma: a critical appraisal of challenging issues Arch Pathol Lab Med 134 2010 837 852
23. th ed 2009 New York Springer
24. G.Y. Locker, S. Hamilton, and J. Harris ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer J Clin Oncol 24 2006 5313 5327
25. J.S. Ross, J. Torres-Mora, and N. Wagle Biomarker-based prediction of response to therapy for colorectal cancer: current perspective Am J Clin Pathol 134 2010 478 490
26. L.L. Gunderson, J.M. Jessup, and D.J. Sargent Revised TN categorization for colon cancer based on national survival outcomes data J Clin Oncol 28 2010 264 271
27. A.R. Folsom, S.A. Kaye, and R.J. Prineas Increased incidence of carcinoma of the breast associated with abdominal adiposity in postmenopausal women Am J Epidemiol 131 1990 794 803
28. B.F. Hankey, L.A. Ries, and B.K. Edwards The surveillance, epidemiology, and end results program: a national resource Cancer Epidemiol Biomarkers Prev 8 1999 1117 1121
29. K.M. Bisgard, A.R. Folsom, and C.P. Hong Mortality and cancer rates in nonrespondents to a prospective study of older women: 5-year follow-up Am J Epidemiol 139 1994 990 1000
30. S. Zhang, A.R. Folsom, and T.A. Sellers Better breast cancer survival for postmenopausal women who are less overweight and eat less fat. The Iowa Women's Health Study Cancer 76 1995 275 283
31. J.E. Lee, Y. Baba, and K. Ng Statin use and colorectal cancer risk according to molecular subtypes in two large prospective cohort studies Cancer Prev Res (Phila) 4 2011 1808 1815
32. E.S. Schernhammer, E. Giovannucci, and Y. Baba B vitamins, methionine and alcohol intake and risk of colon cancer in relation to BRAF mutation and CpG island methylator phenotype (CIMP) PLoS One 6 2011 e21102
33. D. Limsui, R.A. Vierkant, and L.S. Tillmans Cigarette smoking and colorectal cancer risk by molecularly defined subtypes J Natl Cancer Inst 102 2010 1012 1022
34. S. Ogino, T. Kawasaki, and G.J. Kirkner CpG island methylator phenotype-low (CIMP-low) in colorectal cancer: possible associations with male sex and KRAS mutations J Mol Diagn 8 2006 582 588
35. T. Hinoue, D.J. Weisenberger, and C.P. Lange Genome-scale analysis of aberrant DNA methylation in colorectal cancer Genome Res 22 2012 271 282
36. Cancer Genome Atlas Network Comprehensive molecular characterization of human colon and rectal cancer Nature 487 2012 330 337
37. N.J. Samadder, R.A. Vierkant, and L.S. Tillmans Cigarette smoking and colorectal cancer risk by KRAS mutation status among older women Am J Gastroenterol 107 2012 782 789
38. A.A. Razzak, A.S. Oxentenko, and R.A. Vierkant Associations between intake of folate and related micronutrients with molecularly defined colorectal cancer risks in the Iowa Women's Health Study Nutr Cancer 64 2012 899 910
39. Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group, N. Calonge, and N.L. Fisher Recommendations from the EGAPP Working Group: can testing of tumor tissue for mutations in EGFR pathway downstream effector genes in patients with metastatic colorectal cancer improve health outcomes by guiding decisions regarding anti-EGFR therapy? Genet Med 2 2013 Feb 21 10.1038/gim.2012.184 [Epub ahead of print]
40. S. Popat, R. Hubner, and R.S. Houlston Systematic review of microsatellite instability and colorectal cancer prognosis J Clin Oncol 23 2005 609 618
41. C. Guastadisegni, M. Colafranceschi, and L. Ottini Microsatellite instability as a marker of prognosis and response to therapy: a meta-analysis of colorectal cancer survival data Eur J Cancer 46 2010 2788 2798
42. S.N. Thibodeau, A.J. French, and J.M. Cunningham Microsatellite instability in colorectal cancer: different mutator phenotypes and the principal involvement of hMLH1 Cancer Res 58 1998 1713 1718
43. C.P. Raut, T.M. Pawlik, and M.A. Rodriguez-Bigas Clinicopathologic features in colorectal cancer patients with microsatellite instability Mutat Res 568 2004 275 282
44. J. Young, L.A. Simms, and K.G. Biden Features of colorectal cancers with high-level microsatellite instability occurring in familial and sporadic settings: parallel pathways of tumorigenesis Am J Pathol 159 2001 2107 2116
45. L. Barault, C. Charon-Barra, and V. Jooste Hypermethylator phenotype in sporadic colon cancer: study on a population-based series of 582 cases Cancer Res 68 2008 8541 8546
46. J.H. Kim, S.H. Shin, and H.J. Kwon Prognostic implications of CpG island hypermethylator phenotype in colorectal cancers Virchows Arch 455 2009 485 494
47. J.B. Ahn, W.B. Chung, and O. Maeda DNA methylation predicts recurrence from resected stage III proximal colon cancer Cancer 117 2011 1847 1854
48. B. Iacopetta, K. Kawakami, and T. Watanabe Predicting clinical outcome of 5-fluorouracil-based chemotherapy for colon cancer patients: is the CpG island methylator phenotype the 5-fluorouracil-responsive subgroup? Int J Clin Oncol 13 2008 498 503
49. L. Shen, P.J. Catalano, and A.B. Benson 3rd Association between DNA methylation and shortened survival in patients with advanced colorectal cancer treated with 5-fluorouracil based chemotherapy Clin Cancer Res 13 2007 6093 6098
50. K. Curtin, M.L. Slattery, and W.S. Samowitz CpG island methylation in colorectal cancer: past, present and future Pathol Res Int 2011 2011 902674
51. W.S. Samowitz, C. Sweeney, and J. Herrick Poor survival associated with the BRAF V600E mutation in microsatellite-stable colon cancers Cancer Res 65 2005 6063 6069
52. M.F. Kalady, K.L. Dejulius, and J.A. Sanchez BRAF mutations in colorectal cancer are associated with distinct clinical characteristics and worse prognosis Dis Colon Rectum 55 2012 128 133
53. S.D. Richman, M.T. Seymour, and P. Chambers KRAS and BRAF mutations in advanced colorectal cancer are associated with poor prognosis but do not preclude benefit from oxaliplatin or irinotecan: results from the MRC FOCUS trial J Clin Oncol 27 2009 5931 5937
54. B. Tran, S. Kopetz, and J. Tie Impact of BRAF mutation and microsatellite instability on the pattern of metastatic spread and prognosis in metastatic colorectal cancer Cancer 117 2011 4623 4632
55. I. Zlobec, M.P. Bihl, and H. Schwarb Clinicopathological and protein characterization of BRAF- and K-RAS-mutated colorectal cancer and implications for prognosis Int J Cancer 127 2010 367 380
56. A.I. Phipps, D.D. Buchanan, and K.W. Makar BRAF mutation status and survival after colorectal cancer diagnosis according to patient and tumor characteristics Cancer Epidemiol Biomarkers Prev 21 2012 1792 1798
57. T. Yokota, T. Ura, and N. Shibata BRAF mutation is a powerful prognostic factor in advanced and recurrent colorectal cancer Br J Cancer 104 2011 856 862
58. P. Castagnola, and W. Giaretti Mutant KRAS, chromosomal instability and prognosis in colorectal cancer Biochim Biophys Acta 1756 2005 115 125